Medicare Enrolled
Dr. Victor Fariwa, MD
Internal Medicine · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fariwa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fariwa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fariwa
Dr. Victor Fariwa is an internal medicine specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fariwa performed 43,110 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fariwa received a total of $2,379 from 40 pharmaceutical and/or device companies across 134 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fariwa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 0% volume in NY
$2,379 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗43,110
Medicare services
Top 0% in NY for internal medicine
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
8,159 | $81 | $150 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
7,437 | $0 | $50 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
6,945 | $13 | $50 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
3,797 | $0 | $40 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
2,709 | $1 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,663 | $8 | $10 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
1,645 | $1 | $15 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,373 | $51 | $75 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
1,315 | $16 | $40 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
1,202 | $60 | $120 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
1,063 | $35 | $200 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
973 | $16 | $45 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
710 | $68 | $125 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
697 | $3 | $15 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
510 | $4 | $20 |
| Injection, furosemide, up to 20 mg | 472 | $0 | $25 |
| Respiratory syncytial virus (RSV) immunoassay test A laboratory test that uses an immunoassay technique to detect the presence of respiratory syncytial virus in a sample. The results are determined through direct visual observation of the test reaction. |
386 | $13 | $100 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
361 | $13 | $75 |
| Cefazolin sodium injection, 500 mg An injection of 500 mg of cefazolin sodium, an antibiotic medication, administered into the body. |
355 | $1 | $50 |
| Metoclopramide HCl injection, up to 10 mg Administration of metoclopramide hydrochloride medication via injection, with a dosage not exceeding 10 milligrams. |
326 | $1 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
269 | $107 | $200 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
124 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
119 | $49 | $50 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
98 | $43 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
76 | $103 | $175 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
52 | $111 | $400 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
48 | $1 | $10 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
46 | $126 | $1,000 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
39 | $182 | $350 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
38 | $2 | $75 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
34 | $41 | $100 |
| Insertion of temporary bladder tube | 22 | $43 | $200 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
18 | $101 | $330 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
17 | $121 | $150 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
12 | $41 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
3.0% high complexity
55.3% medium
41.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,379
Total received (2018-2024)
Avg $340/year across 7 years
Top 25% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
134
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$337
2023
$405
2022
$166
2021
$344
2020
$142
2019
$509
2018
$476
Payments by company (2024)
HEARTFLOW, INC.
$78
Exact Sciences Corporation
$69
Paratek Pharmaceuticals, Inc.
$49
ABBVIE INC.
$44
AstraZeneca Pharmaceuticals LP
$43
Phathom Pharmaceuticals, Inc.
$29
Amgen Inc.
$25
Top 3 companies account for 58.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$239
Lilly USA, LLC
$162
Amarin Pharma Inc.
$146
Paratek Pharmaceuticals, Inc.
$140
AstraZeneca Pharmaceuticals LP
$119
Janssen Pharmaceuticals, Inc
$115
E.R. Squibb & Sons, L.L.C.
$105
Novartis Pharmaceuticals Corporation
$88
Genentech USA, Inc.
$85
HEARTFLOW, INC.
$78
Abbott Laboratories
$75
Exact Sciences Corporation
$69
Astellas Pharma US Inc
$67
AbbVie Inc.
$66
PFIZER INC.
$64
GlaxoSmithKline, LLC.
$59
Amgen Inc.
$52
Kowa Pharmaceuticals America, Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$46
Esperion Therapeutics, Inc.
$43
Hikma Pharmaceuticals USA
$41
Biohaven Pharmaceuticals, Inc.
$41
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$39
Celgene Corporation
$37
Nevro Corp.
$33
Teva Pharmaceuticals USA, Inc.
$30
Phathom Pharmaceuticals, Inc.
$29
Mylan Specialty L.P.
$26
GENZYME CORPORATION
$25
Sunovion Pharmaceuticals Inc.
$23
Intuity Medical Inc
$23
Horizon Therapeutics plc
$21
ITI, Inc.
$20
Synergy Pharmaceuticals Inc
$19
Merck Sharp & Dohme Corporation
$19
Sumitomo Pharma America, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
West-Ward Pharmaceuticals
$17
Allergan, Inc.
$16
Allergan Inc.
$15
Top 3 companies account for 23.0% of all-time payments
Associated products mentioned in payments ›
AJOVY · AUSTEDO · Amitiza · BASAGLAR · CAPLYTA · CHANTIX · CIPRODEX · CREON · Cologuard Collection Kit · DIFICID · DUPIXENT · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FASENRA · FFRct · GEMTESA · INVOKANA · JARDIANCE · LEQVIO · LINZESS · Livalo · MYRBETRIQ · Mitigare · NEXLETOL · NUCALA · NURTEC ODT · NUZYRA · Omnia · Otezla · PENNSAID · PRADAXA · PREVNAR - 13 · Pacemakers · Pogo Automatic Blood Glucose Monitoring System · Prolia · QULIPTA · SEGLENTIS · SHINGRIX · SYMBICORT · TRULICITY · Trintellix · Trulance · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · XARELTO · XIFAXAN · Xofluza · Yupelri · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
10,599
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
1.5 mi
1.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fariwa is a clinical cardiology specialist, with above-average Medicare volume (top 0% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fariwa experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Fariwa performed 8,159 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fariwa receive payments from pharmaceutical companies?
Yes. Dr. Fariwa received a total of $2,379 from 40 companies across 134 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fariwa's costs compare to other internal medicine physicians in Brooklyn?
Dr. Fariwa's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fariwa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Brooklyn
Browse internal medicine physicians in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology